Autoantibodies against tumor antigens are promising means for cancer diagnosis and
prognosis. In this study, we applied a proteomic approach to identify proteins that commonly …

Our aim was to identify novel tumor-associated antigens from the esophageal squamous cell
carcinoma (ESCC) cell line EC0156, and related autoantibodies in sera from patients with …

The identification of autoantibodies to tumor cell proteins by proteomics approaches has
great potential impact on cancer biomarker discovery. The humoral immune response …

Many studies have demonstrated that intracellular proteins, which are involved in
carcinogenesis, can provoke autoantibody responses. Therefore, autoantibodies can be …

Currently only a limited number of tumor markers for non‐small cell lung cancer (NSCLC)
are available. Antibodies to tumor‐associated proteins may expand the number of available …

Cancer remains one of the leading causes of death worldwide. Thus, to identify any useful
biomarkers is still a need. We performed “cancer immunomics” to identify autoantibody …

Proteome analysis has rapidly developed in the post-genome era and is widely accepted as
a complementary technology to genetic profiling. Sera from tumor patients contain tumor …

BACKGROUND: In this study we applied a serological proteomics-based approach
(SERPA) to identify tumor antigens that commonly induce a humoral immune response in …

The identification of panels of tumor antigens that elicit an antibody response may have
utility in cancer screening, diagnosis, and establishing prognosis. Until now, autoimmunity in …

Lung cancer has the highest mortality rate among cancer patients in the world, in particular
because most patients are only diagnosed at an advanced and noncurable stage …